{
    "Trade/Device Name(s)": [
        "LIAISON\u00ae 25 OH Vitamin D TOTAL Assay",
        "LIAISON\u00ae 25 OH Vitamin D TOTAL Control Set",
        "LIAISON\u00ae 25 OH Vitamin D TOTAL Specimen Diluent Set"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K071480",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032844"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG",
        "JJX"
    ],
    "Summary Letter Date": "September 14, 2007",
    "Summary Letter Received Date": "September 25, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1825"
    ],
    "Regulation Name(s)": [
        "Vitamin D Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "25-hydroxyvitamin D",
        "hydroxylated vitamin D metabolites"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA-plasma",
        "Lithium heparin plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Specimen Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin LIAISON 25 OH Vitamin D TOTAL Assay, Control Set, and Specimen Diluent for quantitative determination of vitamin D metabolites using CLIA technology",
    "Indications for Use Summary": "Quantitative determination of 25-hydroxyvitamin D and other hydroxylated vitamin D metabolites in human serum, EDTA-plasma or lithium heparin plasma for assessment of vitamin D sufficiency in adults; control set for assay QC; diluent set for samples above measurement range",
    "fda_folder": "Clinical Chemistry"
}